Provided sample report
PT-141
BTLabs (Powered by BioTools) · IF-824-QSA-TR006-2025-120-03
Read this document note
Only page 1 of 2 is supplied. Report states tests do not provide information on particulate matter, microbial contamination or endotoxins. HPLC potency shown as 105.7%, while the printed specification is 95-105%; no pass claim is inferred.
- Sample
- PT-141
- Sample specification
- 10 mg
- Laboratory shown
- BTLabs (Powered by BioTools)
- Submitting client shown
- Step One Ventures
- Report number
- IF-824-QSA-TR006-2025-120-03
- Sample lot / batch
- ZG111025S1
- Date reported
- 2025-11-18
| Test shown | Method shown | Reported result |
|---|---|---|
| General Appearance | USP <630> | White powder |
| Mass | USP <41> | 46.9 mg |
| FTIR Identification and Composition Analysis | USP <197A> | FTIR sample spectrum confirms the presence of peptide with addition of excipient(s)/fillers such as mannitol. |
| HPLC Purity of Peptide Assay | USP <621> | 99.9% |
| HPLC Potency Assay | USP <621> | 10.6 mg (105.7%) |
Results are transcribed from this sample report. The original document takes precedence; these results are not specifications or guarantees for other samples.
The submitting client is Step One Ventures. The connection between this sample lot and current NorthVerity inventory has not been established. Request the current lot document with your inquiry.
Related catalog entries
The links below are references based on catalog naming. Confirm the chemical form, blend composition, specification and current inventory lot separately.
Original-file fingerprint
SHA-256: e0f22c7fa6d1002cebc1aa1915e2ea2aaf29ab71c81149b2dd8b3e7a266e6285